Literature DB >> 17975478

The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.

Yasuko Iwakiri1.   

Abstract

A hyperdynamic splanchnic and systemic circulation is typical of cirrhotic patients and has been observed in all experimental forms of portal hypertension. The hyperdynamic circulation is most likely initiated by arterial vasodilatation, leading to central hypovolemia, sodium retention, and an increased intravascular volume. Arterial vasodilatation is regulated by a complex interplay of various vasodilator molecules and factors that influence the production of those vasodilator molecules. Nitric oxide (NO) has been recognized as the most important vasodilator molecule that mediates the excessive arterial vasodilatation observed in portal hypertension. The aims of this review are (1) to categorize NO synthase isoforms involved in NO overproduction; (2) to explain the mechanisms of endothelial NO synthase up-regulation; and (3) to summarize other molecules involved in the arterial vasodilatation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975478     DOI: 10.1097/MCG.0b013e3181468b4c

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  14 in total

Review 1.  Approach to Hyponatremia in Cirrhosis.

Authors:  Bashar Attar
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

Review 2.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 3.  Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Liver Int       Date:  2011-07-05       Impact factor: 5.828

Review 4.  Pathophysiology of portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Clin Liver Dis       Date:  2014-02-25       Impact factor: 6.126

5.  Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients.

Authors:  Sanjeev Kumar Jha; Ashish Kumar; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2008-12-06       Impact factor: 6.047

6.  Management of refractory ascites and hepatorenal syndrome.

Authors:  Amy N Sussman; Thomas D Boyer
Journal:  Curr Gastroenterol Rep       Date:  2011-02

7.  Doppler ultrasound of hepatic and system hemodynamics in patients with alcoholic liver cirrhosis.

Authors:  Drazen Zekanovic; Zekanovic Drazen; Neven Ljubicic; Ljubicic Neven; Marko Boban; Boban Marko; Marko Nikolic; Nikolic Marko; Diana Delic-Brkljacic; Delic-Brkljacic Diana; Petar Gacina; Gacina Petar; Ivo Klarin; Klarin Ivo; Jadranko Turcinov; Turcinov Jadranko
Journal:  Dig Dis Sci       Date:  2009-03-10       Impact factor: 3.199

Review 8.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 9.  The Changing Role of Sodium Management in Cirrhosis.

Authors:  Blanca Lizaola; Alan Bonder; Elliot B Tapper; Angela Mendez-Bocanegra; Andres Cardenas
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

10.  Therapeutic effect of captopril, pentoxifylline, and cordyceps sinensis in pre-hepatic portal hypertensive rats.

Authors:  Ahmed F Ahmed; Nabila N El-Maraghy; Rasha H Abdel Ghaney; Shimaa M Elshazly
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.